Synthokind Pharmaceuticals Private Limited - Company Profile

It is a pharma private limited company based in Delhi, Delhi, India, established in 2014.
2014 Delhi, Delhi, India Active
Last Updated:
Access Report
About Synthokind Pharmaceuticals Private Limited

Synthokind Pharmaceuticals Private Limited, a active private limited company, was established on 01 February 2014 in Delhi, Delhi, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U51909DL2014PTC264328. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

It upholds a compliant status. Its leadership includes Veena Mittal (Director), Amit Mittal (Additional Director). Past directors included Veena Mittal, Amardeep Bansal, Vishav Deep Bansal. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at House No.488, 02Nd Floor, Near Rana Public School, Shahbad Daulatp, Ur, Delhi, Delhi, 110042.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U51909DL2014PTC264328

  • Registration Number

    264328

  • Incorporation Date

    01 February 2014

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Delhi

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 12 Year, 5 Months
  • Last Filing with ROC 31 Mar 2025
  • Revenue Growth **** -0.35%
  • Profit Growth **** -24.44%
  • Ebitda **** -4.70%
  • Net Worth 32.56%
  • Total Assets **** 2.61%
Company report

Synthokind Pharmaceuticals Private Limited

Company Report FY 2026-2027

Comprehensive Company Insights

Explore comprehensive insights into Synthokind Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Synthokind Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Veena Mittal Director 12 Jan 2017 Current
Amit Mittal Additional Director 26 Mar 2018 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 30 Sep 2017 Past
Pramod Abcsdd Director 12 Apr 2014 Past
Pramod Abcsdd Director 09 Jul 2018 Past
Pramod Abcsdd Director 23 Jan 2017 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Synthokind Pharmaceuticals.

Synthokind Pharmaceuticals Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 0.35% decrease. The company also saw a substantial fall in profitability, with a 24.44% decrease in profit. The company's net worth Soared by an impressive increase of 32.56%.

Synthokind Pharmaceuticals revenue growth over time
Synthokind Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 -0.35%
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
 2.61%
*******
*******
*******
*******
Profit or Loss
*******
 -24.44%
*******
*******
*******
*******
Net Worth
*******
 32.56%
*******
*******
*******
*******
EBITDA
*******
 -4.70%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Synthokind Pharmaceuticals?

In 2023, Synthokind Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Synthokind Pharmaceuticals?

Unlock and access historical data on people associated with Synthokind Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Synthokind Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Synthokind Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Synthokind Pharmaceuticals
Recent Activity within the Organization
  • Annual General Meeting

    The activity Synthokind Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was completed.

  • Balance Sheet

    Progress on Synthokind Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi. was documented.

  • Director Appointment

    Amit Mittal was appointed as a Additional Director was appointed as a Additional Director on 26 Mar 2018 & has been associated with this company since 8 years 3 months . was recorded as a recent event.

  • Director Appointment

    Veena Mittal was appointed as a Director was appointed as a Director on 12 Jan 2017 & has been associated with this company since 9 years 5 months . was recorded as a recent event.

  • Company Incorporation

    The activity Synthokind Pharmaceuticals Private Limited was registered on 01 Feb 2014 with Roc Delhi & aged 12 years 5 months as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Synthokind Pharmaceuticals Private Limited?

The CIN of Synthokind Pharmaceuticals Private Limited is U51909DL2014PTC264328.

Where is Synthokind Pharmaceuticals Private Limited headquartered?

Synthokind Pharmaceuticals Private Limited is headquartered at House No.488, 02Nd Floor, Near Rana Public School, Shahbad Daulatp, Ur, Delhi, Delhi, 110042.

When was Synthokind Pharmaceuticals Private Limited incorporated?

Synthokind Pharmaceuticals Private Limited was incorporated on 01 February 2014.

Who are the current directors of Synthokind Pharmaceuticals Private Limited?

The current directors of Synthokind Pharmaceuticals Private Limited are

What is the primary industry of Synthokind Pharmaceuticals Private Limited?

The primary industry of Synthokind Pharmaceuticals Private Limited is Trade.

Is Synthokind Pharmaceuticals Private Limited a listed company?

Synthokind Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Synthokind Pharmaceuticals Private Limited?

The authorized capital of Synthokind Pharmaceuticals Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

What is the compliance status of Synthokind Pharmaceuticals Private Limited?

The compliance status of Synthokind Pharmaceuticals Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available